Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 60
Page 7
... metastatic patterns. Bronchioid tumors are correlated with increased survival in early stage disease, whereas ... metastases. SCLC starts in the hormonal cells in the lungs and multiplies rapidly. The histologic classification of SCLC ...
... metastatic patterns. Bronchioid tumors are correlated with increased survival in early stage disease, whereas ... metastases. SCLC starts in the hormonal cells in the lungs and multiplies rapidly. The histologic classification of SCLC ...
Page 8
... metastasis (TNM) staging classification in Table 1–6 has shown significance and has proven to be beneficial for ... metastases, and mas- sive tumor that would require prohibitive radiation fields (Chao, Perez, & Brady, 2002). The 2-year ...
... metastasis (TNM) staging classification in Table 1–6 has shown significance and has proven to be beneficial for ... metastases, and mas- sive tumor that would require prohibitive radiation fields (Chao, Perez, & Brady, 2002). The 2-year ...
Page 9
... metastasis. N1 Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes involved by direct extension of the primary tumor. N2 Metastasis to ipsilateral mediastinal and/or subcarinal lymph ...
... metastasis. N1 Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes involved by direct extension of the primary tumor. N2 Metastasis to ipsilateral mediastinal and/or subcarinal lymph ...
Page 10
... metastasis (M). Source: Used with the permission of the American Joint Committee on Cancer (AJCC®), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, 6th edition (2002) published by Lippincott ...
... metastasis (M). Source: Used with the permission of the American Joint Committee on Cancer (AJCC®), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, 6th edition (2002) published by Lippincott ...
Page 11
... metastatic nodules located in a different lobe of the ipsilateral lung Regional lymph nodes—No changes to the N descriptors Metastasis—The proposed M descriptors are: • M0: No distant metastasis • M1a: Malignant pleural effusion ...
... metastatic nodules located in a different lobe of the ipsilateral lung Regional lymph nodes—No changes to the N descriptors Metastasis—The proposed M descriptors are: • M0: No distant metastasis • M1a: Malignant pleural effusion ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss